News

  • May 28, 2021

Industry News: Ori Biotech and Vineti have formed strategic partnership to deliver integrated manufacturing and supply chain solutions for cell and gene therapies

Publication: Select Science

Ori Biotech, an innovator in cell and gene therapy manufacturing, and Vineti, a provider of leading digital enterprise platforms for cell and gene therapy supply…

  • May 26, 2021

Ori Biotech and Vineti collaborate on digital platform for CGTs

Publication: Manufacturing Chemist

Ori Biotech and Vineti are partnering to produce an integrated solution to streamline the manufacture and delivery of cell and gene therapies (CGTs).

Ori provides…

  • May 26, 2021

Ori Biotech and Vineti Form Strategic Partnership to Deliver Integrated Manufacturing and Supply Chain Solutions for Cell and Gene Therapies

Press Release

Platform integration will provide therapy developers with full end-to-end visibility, control, and insights into manufacturing and supply chain.

  • May 10, 2021

Vineti Introduces PTM Essentials™ to Accelerate Cell and Gene Therapy Clinical Trials with a New Digital Supply Chain Solution

Press Release

SAN FRANCISCO, May 10, 2021 (GLOBE NEWSWIRE) -- Vineti, the developer of the leading digital platform of record for personalized therapeutics, today announced the release…

  • April 20, 2021

McKesson Ventures highlights investment priorities amidst a trail of successful exits

Publication: MedCity News

McKesson Ventures is one of the most active investors in the biopharma software sector with Vineti, Komodo Health, Evidation and M2Gen among its portfolio companies.…

  • April 8, 2021

Meeting on the Med 2021 | Tackling challenges in industry standardization

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, highlights that despite the exciting pace of scientific discovery within the...

  • April 8, 2021

Meeting on the Med 2021 | Supply chain management & automation

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, describes the Personalized Therapy Management (PTM) platform, enterprise software that aims...

  • April 8, 2021

Meeting on the Med 2021 | International collaboration in advanced therapies

Publication

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, explains that the scientific community’s response to the COVID-19 pandemic has...

  • April 8, 2021

Meeting on the Med 2021 | What can the field learn from the COVID-19 pandemic?

Publication

Amy DuRoss, Co-Founder & CEO, Vineti, San Francisco, CA, discusses the lessons that the field of cell and gene therapy...

  • April 1, 2021

Six Cell and Gene Therapy Commercialization Trends

Publication

Amy DuRoss, CEO and Co-founder, Vineti and Keith Martino, VP/General Manager, Biopharma Services, Cardinal Health Specialty Solutions discuss what to watch in the next 12…

  • March 24, 2021

Biopharmaceutical and technology leaders form collaboration to promote standards and a modern patient ID for advanced therapies

Publication: Globe Newswire

SAN FRANCISCO, March 24, 2021 (GLOBE NEWSWIRE) -- A broad coalition of biopharmaceutical and technology leaders today announced a new strategic collaboration to promote new…

  • March 24, 2021

Exclusive: An industry consortium wants to standardize cell tracking for regenerative meds. Could that avert a disaster?

Publication: Endpoints News

In the fast-moving world of regenerative medicine, the open secret among industry experts is that manufacturing is exceedingly difficult and will take a Herculean effort…